Search Articles

View query in Help articles search

Search Results (1 to 10 of 38 Results)

Download search results: CSV END BibTex RIS


Using an Electronic Immunization Registry (Aplikasi Sehat IndonesiaKu) in Indonesia: Cross-Sectional Study

Using an Electronic Immunization Registry (Aplikasi Sehat IndonesiaKu) in Indonesia: Cross-Sectional Study

During the implementation of this BIAN, for the first time, Indonesia used an electronic immunization registry (EIR) capturing individual-level records [5] and replacing paper-based records as the latter were shown previously to include inaccuracies due to inexact, incomplete data and late reporting [10-12]. EIRs as part of an immunization information system are a tool designed to provide information on immunization programs’ target populations.

Dewi Nur Aisyah, Astri Utami, Fauziah Mauly Rahman, Nathasya Humaira Adriani, Fiqi Fitransyah, M Thoriqul Aziz Endryantoro, Prima Yosephine Hutapea, Gertrudis Tandy, Logan Manikam, Zisis Kozlakidis

Interact J Med Res 2025;14:e53849

Clinical Safety of Pudilan Xiaoyan Oral Liquid for the Treatment of Upper Respiratory Tract Infection in the Real World: Protocol for a Prospective, Observational, Registry Study

Clinical Safety of Pudilan Xiaoyan Oral Liquid for the Treatment of Upper Respiratory Tract Infection in the Real World: Protocol for a Prospective, Observational, Registry Study

This is a prospective, observational, multicenter, hospital-intensive monitoring, and continuous registry study. We used the SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) checklist when writing our report [23]. The study flowchart is shown in Figure 1. Study flowchart. ADR: adverse drug reaction; CRF:case report form; PDL: Pudilan xiaoyan oral liquid.

Mengmeng Wang, Lianxin Wang, Fumei Liu, Renbo Chen, Zhifei Wang, Xin Cui, Yuanyuan Li, Yanming Xie

JMIR Res Protoc 2025;14:e65789

Studies of Artificial Intelligence/Machine Learning Registered on ClinicalTrials.gov: Cross-Sectional Study With Temporal Trends, 2010-2023

Studies of Artificial Intelligence/Machine Learning Registered on ClinicalTrials.gov: Cross-Sectional Study With Temporal Trends, 2010-2023

We conducted a cross-sectional analysis using Clinical Trials.gov, a trial registry and results database maintained by the US National Library of Medicine. We sourced data from the Clinical Trials Transformation Initiative Aggregate Analysis of Clinical Trials.gov (CTTI AACT) [15], which allows open access to the complete set of trials registered in Clinical Trials.gov, including additional fields that are not readily available in direct exports from Clinical Trials.gov.

Shoko Maru, Michael D Matthias, Ryohei Kuwatsuru, Ross J Simpson Jr

J Med Internet Res 2024;26:e57750

Evaluating the “Zindagi Mehfooz” Electronic Immunization Registry and Suite of Digital Health Interventions to Improve the Coverage and Timeliness of Immunization Services in Sindh, Pakistan: Mixed Methods Study

Evaluating the “Zindagi Mehfooz” Electronic Immunization Registry and Suite of Digital Health Interventions to Improve the Coverage and Timeliness of Immunization Services in Sindh, Pakistan: Mixed Methods Study

The Zindagi Mehfooz (safe life; ZM) electronic immunization registry (EIR) is a comprehensive suite of digital health interventions that aims to improve equitable access, timeliness, and coverage of child immunizations through a smartphone-based app for vaccinators, web-based dashboards for supervisors and managers, text message alerts and reminders for caregivers, and a call center. It has been implemented at scale in Sindh Province, Pakistan.

Patricia Mechael, Sara Gilani, Ahsan Ahmad, Amnesty LeFevre, Diwakar Mohan, Asra Memon, Mubarak Taighoon Shah, Danya Arif Siddiqi, Subhash Chandir, Riswana Soundardjee

J Med Internet Res 2024;26:e52792

Identifying Existing Guidelines, Frameworks, Checklists, and Recommendations for Implementing Patient-Reported Outcome Measures: Protocol for a Scoping Review

Identifying Existing Guidelines, Frameworks, Checklists, and Recommendations for Implementing Patient-Reported Outcome Measures: Protocol for a Scoping Review

A review of the Australian New Zealand Clinical Trials Registry indicated that of 13,666 trials registered from 2005 to 2017 in the registry, 6168 (45%) included a PROM [9]. PROMs in clinical trials are important for decision-making among the stakeholders involved, especially in medical device-related trials to measure adverse events and other negative outcomes to assess the safety of a medical device [10].

Randi Thisakya Jayasinghe, Susannah Ahern, Ashika D Maharaj, Lorena Romero, Rasa Ruseckaite

JMIR Res Protoc 2024;13:e52572

Implementing and Evaluating a National Integrated Digital Registry and Clinical Decision Support System in Early Intervention in Psychosis Services (Early Psychosis Informatics Into Care): Co-Designed Protocol

Implementing and Evaluating a National Integrated Digital Registry and Clinical Decision Support System in Early Intervention in Psychosis Services (Early Psychosis Informatics Into Care): Co-Designed Protocol

Integration of a patient-centered digital registry and CDSS for psychosis could be equally transformative and give parity of esteem to one of the most common and disabling sets of mental health disorders—psychosis—where there is already a well-developed national infrastructure of EIP services. To achieve this paradigmatic change in mental health care, our aim is to develop, evaluate, and establish a national psychosis registry and CDSS, known as EPICare (Early Psychosis Informatics into Care) in 3 stages.

Siân Lowri Griffiths, Graham K Murray, Yanakan Logeswaran, John Ainsworth, Sophie M Allan, Niyah Campbell, Richard J Drake, Mohammad Zia Ul Haq Katshu, Matthew Machin, Megan A Pope, Sarah A Sullivan, Justin Waring, Tumelo Bogatsu, Julie Kane, Tyler Weetman, Sonia Johnson, James B Kirkbride, Rachel Upthegrove

JMIR Res Protoc 2024;13:e50177

Durability of the Effectiveness of Heterologous COVID-19 Vaccine Regimens in Thailand: Retrospective Cohort Study Using National Registration Data

Durability of the Effectiveness of Heterologous COVID-19 Vaccine Regimens in Thailand: Retrospective Cohort Study Using National Registration Data

Thailand has maintained a national citizen registry linked to national health databases since 1993 [20]. Specialized registries have been established for COVID-19 testing, COVID-19 cases, and COVID-19 vaccination [21]. By linking these records, we examined a dynamic cohort of the Thai population to assess the durability of VE of heterologous vaccine sequences, providing insights for future pandemics.

Ponlagrit Kumwichar, Chittawan Poonsiri, Siobhan Botwright, Natchalaikorn Sirichumroonwit, Bootsakorn Loharjun, Supharerk Thawillarp, Nontawit Cheewaruangroj, Amorn Chokchaisiripakdee, Yot Teerawattananon, Virasakdi Chongsuvivatwong

JMIR Public Health Surveill 2024;10:e48255

COVID-19 Vaccination Reactions and Risk of Breakthrough Infections Among People With Diabetes: Cohort Study Derived From Community Reporters

COVID-19 Vaccination Reactions and Risk of Breakthrough Infections Among People With Diabetes: Cohort Study Derived From Community Reporters

Here we use a community-based registry in the United States to describe participant-reported data on COVID-19 vaccine side effects and breakthrough infections in people with diabetes and examine whether diabetes medicine use affects the risk of developing vaccine side effects.

Nancy A Dreyer, Kendall B Knuth, Yiqiong Xie, Matthew W Reynolds, Christina D Mack

JMIR Diabetes 2024;9:e45536